Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04971_nanopub.RAxFcSMnzoRqJYy8spKytlPP-IDzfnMOkYzYnu7okvA34#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB04971 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04971 label "Reglixane [drugbank:DB04971]" assertion.
- drugbank:DB04971 seeAlso DB04971 assertion.
- drugbank:DB04971 description "Reglixane, an isoxazolidine-3,5-dione derivative, is being developed by Pfizer for the treatment of diabetes. It is the first non-thiazolidenedione to enter clinical trials." assertion.
- drugbank:DB04971 identifier "drugbank:DB04971" assertion.
- drugbank:DB04971 title "Reglixane" assertion.
- drugbank:DB04971 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB04971 drugbank_vocabulary:drugbank-id "DB04971" assertion.
- drugbank:DB04971 bio2rdf_vocabulary:x-identifiers.org DB04971 assertion.
- drugbank:DB04971 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04971" assertion.
- drugbank:DB04971 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04971 bio2rdf_vocabulary:identifier "DB04971" assertion.